Originally developed for type 2 diabetes, GLP-1s such as semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) have also proven highly effective for chronic weight management
Single-particle structure determination has been carried out with Relion v3.1.2 88 after motion-correction using 5 5 patches 89 and CTF estimation 90
A future generic Ozempic pathway could: reduce payer burden expand formulary access accelerate broader metabolic treatment adoption This is highly relevant as GLP-1 demand keeps expanding beyond diabetes
Understanding these predispositions may help explain individual variation in blood glucose stability and inform a more personalized conversation about donation candidacy with your healthcare provider
It can help with symptoms such as acne and hirsutism (excess hair growth on the face, chest, and back)
Neither medication manages blood sugar or weight to the same degree as newer versions, but these older drugs are still good options for people with mild diabetes who are not overweight